250 related articles for article (PubMed ID: 7713875)
1. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
3. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
4. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
[TBL] [Abstract][Full Text] [Related]
6. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
[TBL] [Abstract][Full Text] [Related]
7. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier.
Brigle KE; Seither RL; Westin EH; Goldman ID
J Biol Chem; 1994 Feb; 269(6):4267-72. PubMed ID: 8307991
[TBL] [Abstract][Full Text] [Related]
8. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.
Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID
J Biol Chem; 1997 Aug; 272(34):21207-12. PubMed ID: 9261128
[TBL] [Abstract][Full Text] [Related]
9. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
Brigle KE; Spinella MJ; Sierra EE; Goldman ID
J Biol Chem; 1995 Sep; 270(39):22974-9. PubMed ID: 7559435
[TBL] [Abstract][Full Text] [Related]
11. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
[TBL] [Abstract][Full Text] [Related]
12. Membrane protein changes in an L1210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier.
Schuetz JD; Westin EH; Matherly LH; Pincus R; Swerdlow PS; Goldman ID
J Biol Chem; 1989 Sep; 264(27):16261-7. PubMed ID: 2777791
[TBL] [Abstract][Full Text] [Related]
13. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
14. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
16. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
17. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
18. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
19. Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities.
Rajgopal A; Sierra EE; Zhao R; Goldman ID
Am J Physiol Cell Physiol; 2001 Nov; 281(5):C1579-86. PubMed ID: 11600421
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells.
Saikawa Y; Knight CB; Saikawa T; Page ST; Chabner BA; Elwood PC
J Biol Chem; 1993 Mar; 268(7):5293-301. PubMed ID: 7680349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
